Connection

David Hoel to Carcinogens

This is a "connection" page, showing publications David Hoel has written about Carcinogens.
Connection Strength

1.258
  1. Nonlinearity of dose-response functions for carcinogenicity. Environ Health Perspect. 1994 Jan; 102 Suppl 1:109-13.
    View in: PubMed
    Score: 0.108
  2. Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: scientific and public health impact. Fundam Appl Toxicol. 1993 May; 20(4):413-36.
    View in: PubMed
    Score: 0.103
  3. Assumptions of the HERP Index. Risk Anal. 1990 Dec; 10(4):623-4; discussion 629-33.
    View in: PubMed
    Score: 0.087
  4. Metabolite-based internal doses used in a risk assessment of benzene. Environ Health Perspect. 1989 Jul; 82:177-84.
    View in: PubMed
    Score: 0.079
  5. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis. 1988 Nov; 9(11):2045-52.
    View in: PubMed
    Score: 0.076
  6. Exploring relationships between mutagenic and carcinogenic potencies. Mutat Res. 1988 Sep; 196(2):161-75.
    View in: PubMed
    Score: 0.075
  7. Issues concerning the estimation of the TD50. Risk Anal. 1987 Dec; 7(4):437-47.
    View in: PubMed
    Score: 0.071
  8. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments. Cancer Res. 1986 Sep; 46(9):4372-8.
    View in: PubMed
    Score: 0.065
  9. Statistical modeling of animal bioassay data with variable dosing regimens: example--vinyl chloride. Risk Anal. 1986 Jun; 6(2):155-66.
    View in: PubMed
    Score: 0.064
  10. An empirical comparison of methods used to estimate carcinogenic potency in long-term animal bioassays: lifetable vs summary incidence data. Fundam Appl Toxicol. 1986 Feb; 6(2):263-9.
    View in: PubMed
    Score: 0.062
  11. Toxicity and carcinogenic potency. Risk Anal. 1985 Dec; 5(4):263-4.
    View in: PubMed
    Score: 0.062
  12. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fundam Appl Toxicol. 1985 Feb; 5(1):79-86.
    View in: PubMed
    Score: 0.058
  13. Design of animal carcinogenicity studies for goodness-of-fit of multistage models. Fundam Appl Toxicol. 1984 Dec; 4(6):949-59.
    View in: PubMed
    Score: 0.058
  14. Nonparametric estimation of the survival function when cause of death is uncertain. Biometrics. 1984 Dec; 40(4):1151-8.
    View in: PubMed
    Score: 0.058
  15. Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science. 1983 Mar 04; 219(4588):1032-7.
    View in: PubMed
    Score: 0.051
  16. Statistical design of toxicity assays: role of genetic structure of test animal population. J Toxicol Environ Health. 1979 Jan; 5(1):89-101.
    View in: PubMed
    Score: 0.038
  17. The effect of dose on cancer latency period. J Environ Pathol Toxicol. 1977 Nov-Dec; 1(2):279-86.
    View in: PubMed
    Score: 0.035
  18. Synergism between sinusoidal-50?Hz magnetic field and formaldehyde in triggering carcinogenic effects in male Sprague-Dawley rats. Am J Ind Med. 2016 07; 59(7):509-21.
    View in: PubMed
    Score: 0.032
  19. Concordance of carcinogenic response between rodent species: potency dependence and potential underestimation. Risk Anal. 1992 Mar; 12(1):115-21.
    View in: PubMed
    Score: 0.024
  20. Epidemiology and the inference of cancer mechanisms. Natl Cancer Inst Monogr. 1985 May; 67:199-203.
    View in: PubMed
    Score: 0.015
  21. Statistical measures of risk. Drug Metab Rev. 1982; 13(5):829-38.
    View in: PubMed
    Score: 0.012
  22. Animal experimentation and its relevance to man. Environ Health Perspect. 1979 Oct; 32:25-30.
    View in: PubMed
    Score: 0.010
  23. Statistical approaches to toxicological data. Environ Health Perspect. 1979 Oct; 32:267-71.
    View in: PubMed
    Score: 0.010
  24. Some practical problems arising from use of the gamma multihit model for risk estimation. J Toxicol Environ Health. 1981 Sep; 8(3):379-86.
    View in: PubMed
    Score: 0.003
  25. A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride. Toxicol Appl Pharmacol. 1980 Aug; 55(1):154-61.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.